| Single treatment |
| Item |
Start |
12 weeks |
|
| n |
Ave.±SD |
n |
Ave.±SD |
p-value1 |
| SBP |
11 |
115.5±27.1 |
11 |
112.3±18.6 |
0.508 |
| DBP |
11 |
74.3±16.3 |
11 |
72.6±12.5 |
0.6382 |
| Puls |
11 |
73.3±11 |
11 |
69.7±12.9 |
0.3365 |
| BUN |
11 |
14±4.9 |
11 |
13.3±2.8 |
0.5577 |
| CRE |
11 |
0.64±0.09 |
11 |
0.65±0.1 |
0.4579 |
| AST |
11 |
19±3.4 |
11 |
19.2±4.8 |
0.8591 |
| ALT |
11 |
16±4.4 |
11 |
17.2±4.1 |
0.4802 |
| ALP |
11 |
189±28.8 |
11 |
185.5±36.1 |
0.556 |
| LDH |
11 |
193.3±61.6 |
11 |
182.1±29.4 |
0.4305 |
| γ-GTP |
11 |
22±10 |
11 |
19.7±7.8 |
0.203 |
| CRP |
11 |
0.05±0.03 |
11 |
0.08±0.09 |
0.2745 |
| WBC |
11 |
6554.5±1465.9 |
11 |
5990.9±1363.4 |
0.1034 |
| RBC |
11 |
451.2±41.9 |
11 |
450.6±41.1 |
0.9334 |
| Hgb |
11 |
13.8±1.3 |
11 |
13.7±1.2 |
0.6116 |
| PLT |
11 |
26.9±6 |
11 |
25.5±6.2 |
0.242 |
| |
11 |
100±0 |
11 |
100±0 |
- |
| Eos |
11 |
1±1 |
11 |
0.8±0.8 |
0.6761 |
| Baso |
11 |
2.1±1.8 |
11 |
3±2.6 |
0.4171 |
| Neut-Stab |
11 |
2±1 |
11 |
1.6±0.8 |
0.3705 |
| Neut-Seg |
11 |
58.9±11.1 |
11 |
50.8±6 |
0.0569 |
| Ly |
11 |
32±9.1 |
11 |
37.9±7 |
0.1246 |
| Mono |
11 |
4±2.3 |
11 |
5.8±3.7 |
0.1852 |
|
| Table 9: (a) Showing single treatment blood test results. |
| Combined treatment |
| Item |
Start |
12 weeks |
Abort |
|
| n |
Ave.±SD |
n |
Ave.±SD |
n |
Ave.±SD |
p-value1 |
| SBP |
20 |
118.2±24.1 |
17 |
117.2±13.7 |
2 |
127±32.5 |
0.687 |
| DBP |
20 |
77.5±15.1 |
17 |
76.6±13.9 |
2 |
72.5±3.5 |
0.777 |
| Puls |
20 |
76.2±14.4 |
17 |
75.4±11.5 |
2 |
66±5.7 |
0.8455 |
| BUN |
20 |
14.5±3.1 |
17 |
13.6±3.1 |
2 |
10.5±3.5 |
0.1762 |
| CRE |
20 |
0.67±0.1 |
17 |
0.72±0.14 |
2 |
0.6±0.1 |
0.003 |
| AST |
20 |
22.8±9.2 |
17 |
21.9±11.8 |
2 |
19±1.4 |
0.1441 |
| ALT |
20 |
23.2±15 |
17 |
23.9±20.1 |
2 |
13±1.4 |
0.6551 |
| ALP |
20 |
188.6±38.6 |
17 |
195.2±37 |
2 |
191±67.9 |
0.3037 |
| LDH |
20 |
168.7±29.2 |
17 |
174.7±27.5 |
2 |
173.5±33.2 |
0.6236 |
| γ-GTP |
20 |
29±25.3 |
17 |
29.5±24.8 |
2 |
14.5±3.5 |
0.3906 |
| CRP |
20 |
0.07±0.08 |
17 |
0.08±0.09 |
2 |
0.04±0.01 |
0.4484 |
| WBC |
20 |
5315±1458.3 |
17 |
5705.9±2011.7 |
2 |
4050±1343.5 |
0.4471 |
| RBC |
20 |
450.2±51 |
17 |
454.9±57.5 |
2 |
428.5±26.2 |
0.8707 |
| Hgb |
20 |
13.5±1.5 |
17 |
13.6±1.6 |
2 |
13.4±1.8 |
0.7747 |
| PLT |
20 |
24.2±4.2 |
17 |
24.2±5 |
2 |
25.4±3 |
0.8832 |
| |
20 |
100±0 |
17 |
100±0 |
2 |
100±0 |
- |
| Eos |
20 |
0.9±0.9 |
17 |
0.8±0.9 |
2 |
2±1.4 |
0.8899 |
| Baso |
20 |
2.7±2.2 |
17 |
4.9±4.3 |
2 |
5±7.1 |
0.0765 |
| Neut |
1 |
55.1 |
- |
- |
- |
- |
- |
| Neut-Stab |
19 |
1.5±0.6 |
16 |
1.6±0.7 |
2 |
2±0 |
0.5805 |
| Neut-Seg |
19 |
56.5±7.8 |
16 |
53.8±8.1 |
2 |
55.5±12 |
0.3085 |
| Ly |
20 |
33.9±7.7 |
17 |
33.6±6.9 |
2 |
30.5±4.9 |
0.897 |
| Mono |
20 |
4.8±2.3 |
17 |
5±1.6 |
2 |
5±1.4 |
0.6925 |
1. Comparison between start and 12 weeks within each group using the paired t-test.
2. Comparison between groups using the paired t-test (start).
3. Comparison between groups using the paired t-test (12 weeks). |
|
| Table 9: (b) Showing combined treatment blood test results. |
| Between groups |
| p-value2 |
p-value3 |
| 0.7848 |
0.4283 |
| 0.5895 |
0.4446 |
| 0.5636 |
0.2387 |
| 0.753 |
0.7507 |
| 0.4678 |
0.1632 |
| 0.2019 |
0.4712 |
| 0.1326 |
0.2837 |
| 0.9763 |
0.497 |
| 0.1407 |
0.5051 |
| 0.3886 |
0.2207 |
| 0.5107 |
0.9164 |
| 0.0315 |
0.6841 |
| 0.9548 |
0.8339 |
| 0.5729 |
0.7551 |
| 0.1522 |
0.5415 |
| - |
- |
| 0.7063 |
0.9869 |
| 0.4681 |
0.2024 |
| - |
- |
| 0.0832 |
0.8063 |
| 0.4943 |
0.306 |
| 0.5516 |
0.119 |
| 0.378 |
0.4285 |
|
| Table 9: Blood test results. |
